Science News
from research organizations

Targeting A Pathological Area Using MRI

Date:
May 22, 2008
Source:
CNRS
Summary:
Magnetic resonance imaging (MRI) has become a common tool in clinical diagnosis due to the use of contrast agents, which are like colorants, enabling the contrast between healthy tissue and diseased tissue to be increased. However, the agents currently used clinically do not allow the identification of particular pathologies or of the affected area of the body. The recent work has brought new hope to this field.
Share:
       
FULL STORY

In the diagram, the light bulb represents the contrast agent. If the enzyme is present, the contrast agent is activated and "lights up", making it detectable in an MRI image.
Credit: Copyright ICSN

Magnetic resonance imaging (MRI) has become a common tool in clinical diagnosis due to the use of contrast agents, which are like colorants, enabling the contrast between healthy tissue and diseased tissue to be increased. However, the agents currently used clinically do not allow the identification of particular pathologies or of the affected area of the body. The recent work of two CNRS teams from Orleans and Gif-sur-Yvette (Orleans' Centre de biophysique moléculaire and the Institut de chimie des substances naturelles in Gif-sur-Yvette) has brought hope in this field.

CNRS researchers have demonstrated that by using a new class of contrast agents sensitive to enzymes, it is possible to locate the affected part of the body. The molecules act as molecular switches – when they encounter a specific enzyme, this sets off a cascade reaction, leading to the activation of the contrast agent which then becomes detectable in an MRI image. The systems have two positions – they are “off” in the absence of the enzyme, and “on” if it is present. Therefore, an image is only received when the contrast agents are activated.

The reactions caused by certain enzymes may be an indication of the state of the cells, and be interpreted as the signature of a given pathology. In the future, detection of enzymes thanks to these contrast agents should enable doctors to diagnose a disease  with a simple MRI examination. Furthermore, the system can be modulated and is potentially applicable to a great variety of enzymes, and, therefore, pathologies.

Understanding the mechanism of these new molecules for medical imaging constitutes a major advance in visualizing molecular processes in vivo, as well as in detecting pathologies.


Story Source:

The above post is reprinted from materials provided by CNRS. Note: Materials may be edited for content and length.


Journal Reference:

  1. Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Thomas Chauvin, Philippe Durand, Michèle Bernier, Hervé Meudal, Bich-Thuy Doan, Fanny Noury, Bernard Badet, Jean-Claude Beloeil, Eva Jakab Toth, Angewandte Chemie International Edition, Online. doi:10.1002/anie.200800809 [link]

Cite This Page:

CNRS. "Targeting A Pathological Area Using MRI." ScienceDaily. ScienceDaily, 22 May 2008. <www.sciencedaily.com/releases/2008/05/080519154844.htm>.
CNRS. (2008, May 22). Targeting A Pathological Area Using MRI. ScienceDaily. Retrieved September 3, 2015 from www.sciencedaily.com/releases/2008/05/080519154844.htm
CNRS. "Targeting A Pathological Area Using MRI." ScienceDaily. www.sciencedaily.com/releases/2008/05/080519154844.htm (accessed September 3, 2015).

Share This Page: